V021-5302 Screening compound: N-({[1-(4-fluorophenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(propan-2-yl)propanamide

V021-5302 Screening compound: N-({[1-(4-fluorophenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(propan-2-yl)propanamide
V021-5302 Screening compound: N-({[1-(4-fluorophenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(propan-2-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-5302
N-({[1-(4-fluorophenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(propan-2-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-5302

Molecular Formula

C24H27FN4O3 (C24 H27 FN4 O3)

Compound Name

N-({[1-(4-fluorophenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(propan-2-yl)propanamide

IUPAC name

N-({[1-(4-fluorophenyl)-4-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(propan-2-yl)propanamide

SMILES

CCC(N(CC(Nc1nc(-c(cc2)ccc2OC)cn1-c(cc1)ccc1F)=O)C(C)C)=O

InChI

InChI=1S/C24H27FN4O3/c1-5-23(31)28(16(2)3)15-22(30)27-24-26-21(17-6-12-20(32-4)13-7-17)14-29(24)19-10-8-18(25)9-11-19/h6-14,16H,5,15H2,1-4H3,(H,26,27,30)

InChI Key

YFCQHBIKTJIGQO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19825492

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

438.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.624

Distribution Coefficient, logD

4.624

Water Solubility, LogSw

-4.16

Polar Surface Area

59.696

Acid Dissociation Constant (pKa)

12.87

Base Dissociation Constant (pKb)

2.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

V021-5302 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V021-5302 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-5302?
Check Price and Availability of V021-5302, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-5302 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-5302
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-5302
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-5302 available by request